Dourador E B, de Falco V, Chahade W H, Cossermelli W, Yoshinari N H
Disciplina de Reumatologia, Faculdade de Medicina, Universidade de São Paulo-FMUSP.
Rev Hosp Clin Fac Med Sao Paulo. 1997 Mar-Apr;52(2):60-2.
In the recent years, many authors had studied the relationship between the calciotropic and gonadotropic hormones actions on postmenopausal bone loss, named calcium negative balance, with different results (Riggs et al 1983; Prince et al, 1995). We evaluated 187 female patients, aged 40 to 80 with the following distribution: 24 normals, 49 patients with osteopenia and 114 patients with osteoporosis, according to WHO classification. The aim of this study was to analyse the relationship between biochemical parameters (seric and urinary calcium), gonadotropic (seric FSH-foliculi stimulant-hormone and seric oestradiol) and calciotropic hormone (PTH) and postmenopausal bone loss. The results had shown the diminution on bone mineral density was related with elevated levels of FSH (p < 0.00001), lower levels of oestradiol (p < 0.00001) and, however, no differences on seric and urinary calcium (respectively, p > 0.70 and p > 0.52) or PTH (p > 0.70) were demonstrated.
近年来,许多作者研究了促钙激素和促性腺激素对绝经后骨质流失(即钙负平衡)的作用之间的关系,结果各异(里格斯等人,1983年;普林斯等人,1995年)。我们根据世界卫生组织的分类标准,对187名年龄在40至80岁的女性患者进行了评估,其分布如下:24名正常女性,49名骨质减少患者,114名骨质疏松患者。本研究的目的是分析生化参数(血清和尿钙)、促性腺激素(血清促卵泡刺激素和血清雌二醇)和促钙激素(甲状旁腺激素)与绝经后骨质流失之间的关系。结果表明,骨矿物质密度的降低与促卵泡刺激素水平升高(p < 0.00001)、雌二醇水平降低(p < 0.00001)有关,然而,血清和尿钙(分别为p > 0.70和p > 0.52)或甲状旁腺激素(p > 0.70)并无差异。